NU SKIN: No Charter/Bylaw Amendments or Fiscal Year Change

TL;DR

**Nu Skin filed an 8-K confirming no changes to its corporate charter or fiscal year.**

AI Summary

On February 5, 2024, NU SKIN ENTERPRISES, INC. filed an 8-K to report no changes to its Articles of Incorporation or Bylaws, nor any change in its fiscal year. This filing simply confirms that no significant corporate governance or financial calendar alterations occurred, which matters to investors as it indicates stability in the company's foundational structure and reporting schedule, avoiding potential disruptions or strategic shifts that such amendments might signal.

Why It Matters

This filing confirms stability in Nu Skin's corporate governance and financial reporting, reassuring investors that no immediate structural changes are underway.

Risk Assessment

Risk Level: low — The filing indicates no changes to corporate structure or fiscal year, suggesting stability and low immediate risk.

Analyst Insight

A smart investor would note this filing confirms no immediate changes to Nu Skin's corporate structure or fiscal year, suggesting business as usual. This provides no new actionable information for buying or selling based on governance changes.

Key Players & Entities

• NU SKIN ENTERPRISES, INC. (company) — the registrant filing the 8-K
• February 5, 2024 (date) — date of earliest event reported
• Delaware (company) — state of incorporation for Nu Skin
• 001-12421 (company) — Commission File Number for Nu Skin
• 87-0565309 (company) — IRS Employer Identification Number for Nu Skin
• 75 West Center Street Provo, Utah 84601 (company) — principal executive offices address for Nu Skin
• 801-345-1000 (company) — telephone number for Nu Skin

FAQ

Filing Documents

• ef20020750_8k.htm (8-K) — 36KB
• ef20020750_ex3-1.htm (EX-3.1) — 118KB
• 0001140361-24-005870.txt ( ) — 320KB
• nus-20240205.xsd (EX-101.SCH) — 4KB
• nus-20240205_lab.xml (EX-101.LAB) — 23KB
• nus-20240205_pre.xml (EX-101.PRE) — 16KB
• ef20020750_8k_htm.xml (XML) — 4KB

03

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On February 5, 2024, the Board of Directors of Nu Skin Enterprises, Inc. (the "Company") approved and adopted the Fifth Amended and Restated Bylaws of the Company (as so amended and restated, the "Bylaws"), which became effective upon such approval and adoption. As so amended, the Bylaws, among other things: Align and conform to the current provisions of the Delaware General Corporation Law (the "DGCL"), including, without limitation: o align the requirement regarding the availability of the stockholder list with DGCL Section 219 and o clarify the manner in which a stockholder meeting (including a virtual meeting) may be adjourned without having to provide additional notice in accordance with DGCL Section 222. Align and conform certain provisions to the provisions of the Company's certificate of incorporation. Require a stockholder soliciting proxies from other stockholders to use a proxy card color other than white. Clarify the ability of the chairman of a stockholder meeting to prescribe rules and regulations for the conduct of the meeting. Update the procedural and disclosure requirements for stockholders intending to nominate director candidates or propose other business (other than proposals submitted under Rule 14a-8 under the Securities Exchange Act of 1934 (the "Exchange Act")) at stockholder meetings, including, without limitation, to: o revise the default deadline for advance notice of stockholder nominations and proposals to be not less than 90 days nor more than 120 days prior to the anniversary date of the last annual meeting of stockholders, o clarify that any stockholder intending to nominate director candidates at a special meeting held for director elections must comply with the advance notice procedures and requirements applicable to annual meetings, o require a nominating or proposing stockholder to (i) make a representation (x) in the case o

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. 3.1 Fifth Amended and Restated Bylaws of Nu Skin Enterprises, Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NU SKIN ENTERPRISES, INC. (Registrant) /s/ James D. Thomas James D. Thomas Chief Financial Officer Date: February 6, 2024

View Full Filing

View this 8-K filing on SEC EDGAR